Nuwellis, Inc. (NUWE)
0.3221
-0.17
(-33.97%)
USD |
NASDAQ |
Oct 23, 16:00
0.3402
+0.02
(+5.62%)
After-Hours: 20:00
Nuwellis Enterprise Value : -3.527M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -3.527M |
| October 22, 2026 | -3.432M |
| October 21, 2026 | -3.412M |
| October 20, 2026 | -3.396M |
| October 19, 2026 | -3.391M |
| October 16, 2026 | -3.397M |
| October 15, 2026 | -3.394M |
| October 14, 2026 | -3.408M |
| October 13, 2026 | -3.355M |
| October 12, 2026 | -3.327M |
| October 09, 2026 | -3.316M |
| October 08, 2026 | -3.324M |
| October 07, 2026 | -3.315M |
| October 06, 2026 | -3.309M |
| October 05, 2026 | -3.313M |
| October 02, 2026 | -3.313M |
| October 01, 2026 | -3.282M |
| September 30, 2026 | -3.298M |
| September 29, 2026 | -3.284M |
| September 28, 2026 | -3.275M |
| September 25, 2026 | -3.266M |
| September 24, 2026 | -3.248M |
| September 23, 2026 | -3.224M |
| September 22, 2026 | -3.237M |
| September 21, 2026 | -3.21M |
| Date | Value |
|---|---|
| September 18, 2026 | -3.197M |
| September 17, 2026 | -3.086M |
| September 16, 2026 | -3.244M |
| September 15, 2026 | -3.227M |
| September 14, 2026 | -3.254M |
| September 11, 2026 | -3.267M |
| September 10, 2026 | -3.271M |
| September 09, 2026 | -3.252M |
| September 08, 2026 | -3.259M |
| September 04, 2026 | -3.263M |
| September 03, 2026 | -3.290M |
| September 02, 2026 | -3.287M |
| September 01, 2026 | -3.277M |
| August 31, 2026 | -3.257M |
| August 28, 2026 | -3.201M |
| August 27, 2026 | -3.144M |
| August 26, 2026 | -3.132M |
| August 25, 2026 | -3.161M |
| August 24, 2026 | -3.109M |
| August 21, 2026 | -3.046M |
| August 20, 2026 | -3.069M |
| August 19, 2026 | -3.040M |
| August 18, 2026 | -3.028M |
| August 17, 2026 | -2.988M |
| August 14, 2026 | -2.959M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| GlucoTrack, Inc. | 1.003M |
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.828M |
| Revenue (Quarterly) | 1.969M |
| Total Expenses (Quarterly) | 6.797M |
| EPS Diluted (Quarterly) | -26.63 |
| Gross Profit Margin (Quarterly) | 76.08% |
| Profit Margin (Quarterly) | -245.2% |
| Earnings Yield | -42.24K% |
| Normalized Earnings Yield | -76524.84 |